VIDEO: RuxoBEAT study probes ruxolitinib therapy in polycythemia vera
Click Here to Manage Email Alerts
In this video, John Mascarenhas, MD, discussed the RuxoBEAT study into ruxolitinib treatment in patients with polycythemia vera, which was presented at the ASH Annual Meeting and Exposition.
Mascarenhas, professor of medicine at the Icahn School of Medicine at Mount Sinai, discussed the study, which looked into ruxolitinib as a first-line treatment versus best available therapy, and saw “intriguing” results.
“It’s suggesting that ruxolitinib could have the potential to modify the disease biology and the disease outcome. And it will be interesting to see with follow-up of the RuxoBEAT study, whether continued exposure of ruxolitinib earlier on also modulates the disease and longer term outcome measures,” Mascarenhas said.
Collapse
Read more about
Click Here to Manage Email Alerts